XRCC4 and neoplasm: During the initial pro-survival signaling, the enhanced repair capacity by XRCC4 upregulation in retinoblastoma cells would reduce p53-mediated apoptosis and may even generate new genetic mutations conducive to tumor cell survival due to the error-prone nature of NHEJ repair.